PRODUCT DETAIL

Dasatinib Krka 70 mg filmom obalené tablety

Code

2556D

MA number

44/0320/19-S

Product Form:

tbl flm 60x70 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

KRKA, d.d., Novo mesto, Slovenia

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EA	BCR-ABL tyrosine kinase inhibitors
L01EA02	Dasatinib

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	09.10.2019
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
PIL:	PIL_Dasatinib Krka 70 mg filmom obalené tablety_10.2022.pdf
SPC:	SPC_Dasatinib Krka 70 mg filmom obalené tablety_09.2023.pdf
Safety feature	Yes
Data update:	12.11.2024